Session

Liver & biliary (Posters)

INDICATORS OF THE MAIN PHYLOTYPES OF THE INTESTINAL MICROBIOTA AND VISCERAL OBESITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
INDICATORS OF THE MAIN PHYLOTYPES OF THE INTESTINAL MICROBIOTA AND VISCERAL OBESITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

WILSON’S DISEASE DIAGNOSIS IN PAEDIATRIC AGE
WILSON’S DISEASE DIAGNOSIS IN PAEDIATRIC AGE

IMPACT OF RENAMING NAFLD TO MAFLD IN A SINGLE ITALIAN CENTER
IMPACT OF RENAMING NAFLD TO MAFLD IN A SINGLE ITALIAN CENTER

SZN-043 INDUCED QUICK AND ROBUST HEPATOCYTE PROLIFERATION IN A 14-DAY DAILY DOSING EDU-LABELING STUDY IN SCID MICE
SZN-043 INDUCED QUICK AND ROBUST HEPATOCYTE PROLIFERATION IN A 14-DAY DAILY DOSING EDU-LABELING STUDY IN SCID MICE

TRAINED IMMUNITY IN LIVER CIRRHOSIS: FROM MOLECULAR MECHANISMS TO PROGNOSIS IMPLICATIONS. A PRELIMINARY OBSERVATION
TRAINED IMMUNITY IN LIVER CIRRHOSIS: FROM MOLECULAR MECHANISMS TO PROGNOSIS IMPLICATIONS. A PRELIMINARY OBSERVATION

THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION: A MATTER OF BODY COMPOSITION
THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION: A MATTER OF BODY COMPOSITION

BACTERIOPHAGES TO TREAT LIVER DISEASE ELIMINATING HARMFUL BACTERIA (BATTLE) - STUDY PROTOCOL
BACTERIOPHAGES TO TREAT LIVER DISEASE ELIMINATING HARMFUL BACTERIA (BATTLE) - STUDY PROTOCOL

PREVALENCE AND PATTERN OF ALCOHOL CONSUMPTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
PREVALENCE AND PATTERN OF ALCOHOL CONSUMPTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

OSEPHAGEAL VARICEAL RECURRENCE 4 YEARS BEYOND ENDOSCOPIC BAND LIGATION IN HEPATITIS C PATIENTS WHO ACHIEVED SUSTAINED VIROLOGICAL RESPONSE WITH ORAL DIRECT ACTING ANTIVIRAL THERAPIES
OSEPHAGEAL VARICEAL RECURRENCE 4 YEARS BEYOND ENDOSCOPIC BAND LIGATION IN HEPATITIS C PATIENTS WHO ACHIEVED SUSTAINED VIROLOGICAL RESPONSE WITH ORAL DIRECT ACTING ANTIVIRAL THERAPIES

ROLE OF OSTEOPONTIN AS A POTENTIAL SERUM MARKER OF HCV RELATED HEPATOCELLULAR CARCINOMA
ROLE OF OSTEOPONTIN AS A POTENTIAL SERUM MARKER OF HCV RELATED HEPATOCELLULAR CARCINOMA

LONG-TERM EFFICACY OF PLASTIC VERSUS METAL STENTS IN INOPERABLE PERIHILAR CHOLANGIOCARCINOMA; A RETROSPECTIVE COHORT STUDY
LONG-TERM EFFICACY OF PLASTIC VERSUS METAL STENTS IN INOPERABLE PERIHILAR CHOLANGIOCARCINOMA; A RETROSPECTIVE COHORT STUDY

HIGH SERO-PREVALENCE OF HEPATITIS E VIRUS AMONG HEALTHY ASYMPTOMATIC BLOOD DONORS IN PAKISTAN: CAN THE RISK OF TRANSFUSION DEPENDENT TRANSMISSION BE IGNORED?
HIGH SERO-PREVALENCE OF HEPATITIS E VIRUS AMONG HEALTHY ASYMPTOMATIC BLOOD DONORS IN PAKISTAN: CAN THE RISK OF TRANSFUSION DEPENDENT TRANSMISSION BE IGNORED?

LONG-TERM OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: A SINGLE CENTER 20 YEARS EXPERIENCE
LONG-TERM OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: A SINGLE CENTER 20 YEARS EXPERIENCE

SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES
SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES

RELATION OF PROTEIN S AND PORTAL VEIN THROMBOSIS IN EGYPTIAN PATIENTS WITH HCV RELATED LIVER CIRRHOSIS
RELATION OF PROTEIN S AND PORTAL VEIN THROMBOSIS IN EGYPTIAN PATIENTS WITH HCV RELATED LIVER CIRRHOSIS

AUTOIMMUNE HEPATITIS FOLLOWING COVID-19 VACCINE
AUTOIMMUNE HEPATITIS FOLLOWING COVID-19 VACCINE

COMPREHENSIVE MRNA EXPRESSION PROFILE AND IDENTIFICATION OF CRUCIAL GENES IN LIVER REGENERATION
COMPREHENSIVE MRNA EXPRESSION PROFILE AND IDENTIFICATION OF CRUCIAL GENES IN LIVER REGENERATION

IMPACT OF THE COVID-19 PANDEMIC IN THE DIAGNOSIS AND THERAPY OF SINGLE HEPATOCELLULAR CARCINOMA LESS THAN 3 CM IN A WESTERN COUNTRY
IMPACT OF THE COVID-19 PANDEMIC IN THE DIAGNOSIS AND THERAPY OF SINGLE HEPATOCELLULAR CARCINOMA LESS THAN 3 CM IN A WESTERN COUNTRY

KNOCKDOWN OF HSDL2 PROMOTES CELL PROLIFERATION, MIGRATION AND INVASION BY INHIBITING FERROPTOSIS VIA P53PATHWAY IN CHOLANGIOCARCINOMA
KNOCKDOWN OF HSDL2 PROMOTES CELL PROLIFERATION, MIGRATION AND INVASION BY INHIBITING FERROPTOSIS VIA P53PATHWAY IN CHOLANGIOCARCINOMA

LIFESTYLE IN PRIMARY BILIARY CHOLANGITIS: LET’S PAY ATTENTION!
LIFESTYLE IN PRIMARY BILIARY CHOLANGITIS: LET’S PAY ATTENTION!

Item 81 - 100 / 226
1 2 3 4
5
6 7 8 9 10 11 12